A Safety Study of ABI-007 for In-Stent Restenosis

Summary

This trial will treat patients with a new chemotherapeutic medicine who have undergone a successful and uncomplicated de novo stent placement in up to two native coronary arteries. The purpose of the trial is to determine the appropriate dose of the new medicine for future trials and to evaluate the incidence of treatment-emergent adverse events and serious adverse events.

Timeline

Start

2001-09-01

Primary completion

2007-12-01

Completion

2007-12-01

Drugs

Indications